The impact of non-culture diagnostics is evident in the clinic, but it is essential that future developments are exploited to meeting emerging clinical needs (e.g. antifungal resistance).
This presentation will describe the development of novel diagnostics approaches, but more so how recent advances (e.g. Next generation sequencing, predictive modeling and syndromic approaches) can be used to enhance the management of patients at risk from, or diagnosed with fungal disease.
Full conference title:
- Fungal Update 2018